(1R)-2,2'-(2,2'-Bis(methoxymethoxy)-6,6'-bis(perfluoropropan-2-yl)-[1,1'-binaphthalene]-3,3'-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)

Catalog No. :
ACLKVT828
CAS No. :
2755713-15-4
Molecular Formula :
C42H42B2F14O8
Molecular Weight :
962.39

IUPAC Name:2,2'-(2,2'-bis(methoxymethoxy)-6,6'-bis(perfluoropropan-2-yl)-[1,1'-binaphthalene]-3,3'-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)

(1R)-2,2'-(2,2'-Bis(methoxymethoxy)-6,6'-bis(perfluoropropan-2-yl)-[1,1'-binaphthalene]-3,3'-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R)-2,2'-(2,2'-Bis(methoxymethoxy)-6,6'-bis(perfluoropropan-2-yl)-[1,1'-binaphthalene]-3,3'-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
IUPAC Name2,2'-(2,2'-bis(methoxymethoxy)-6,6'-bis(perfluoropropan-2-yl)-[1,1'-binaphthalene]-3,3'-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
Molecular FormulaC42H42B2F14O8
Molecular Weight962.39
SMILESFC(F)(F)C(C1=CC2=CC(B3OC(C)(C)C(C)(C)O3)=C(OCOC)C(C4=C5C=CC(C(C(F)(F)F)(F)C(F)(F)F)=CC5=CC(B6OC(C)(C)C(C)(C)O6)=C4OCOC)=C2C=C1)(F)C(F)(F)F
InChI KeyGAJQKKBIZIJVAY-UHFFFAOYSA-N
CAS No.2755713-15-4

Synthetic Route by SureRoute

1. ACLKVT828 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKVT828 route product structure diagram
    ACLKVT8282755713-15-4
Inquiry

2. ACLKVT828 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKVT828 route product structure diagram
    ACLKVT8282755713-15-4
Inquiry

Comments (0)